Inactive Instrument

Terrace Global Inc.

TRCE

CA88105D1006

Apolo II Acquisition Corp. announced that it has received CAD 17 million in funding

November 18, 2019

Apolo II Acquisition Corp. (TSXV:TRCE) announced a brokered private placement of subscription receipts for aggregate gross proceeds of CAD 17 million at a price of CAD 0.50 per subscription receipt on November 18, 2019.

Latest news about Terrace Global Inc.

The Flowr Corporation (TSX.V:FLWR) completed the acquisition of Terrace Global Inc. from Directors, senior officers of Terrace Global and others.	22/20/22	CI
The Flowr Corporation announced that it has received CAD 5.8186 million in funding from Terrace Global Inc.	17/20/17	CI
Terrace Global Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	01/20/01	CI
The Flowr Corporation (TSX.V:FLWR) entered into a definitive agreement to acquire Terrace Global Inc. (TSX.V: TRCE) from Directors, senior officers of Terrace Global and others for CAD 68.6 million.	20/20/20	CI
Terrace Global Announces Receipt of Pre-License for Outdoor Medical Cannabis Cultivation in Portugal	18/20/18	CI
Terrace Global Inc. announced that it has received CAD 15 million in funding from 2646015 Ontario Inc., Apolo Capital Advisory Corp., and other investors	09/20/09	CI
Terrace Global to Pursue Strategic Alternatives	09/20/09	CI
Terrace Global Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31	CI
Terrace Global Inc Updates on $15 Million Financing	27/20/27	CI
Terrace Global Inc. announced that it expects to receive CAD 15 million in funding	17/20/17	CI
Terrace Global Announces Appointment of Hess Moallem to International Advisory Board	09/20/09	CI
Terrace Global Inc. Provides Operational Update at Aljustrel, Portugal Outdoor Medical Cannabis Site Jointly Operated with The Flowr Corporation	09/20/09	CI
Terrace Global Inc. Enters into an Equity Line and Profit-Sharing Agreement with The Flowr Corporation	14/20/14	CI
The Flowr Corporation announced that it expects to receive CAD 3 million in funding from Terrace Global Inc.	14/20/14	CI
Terrace Global Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	30/20/30	CI
Terrace Global Inc. Suspends All Non Essential Operations	22/20/22	CI
Terrace Global Inc. Appoints Stephen Lermer as President and Chief Operating Officer	03/20/03	CI
Terrace Global Announces Genetics Supply Agreement with Apollo Green for Acquisition of Genetics and Importation into the European Union	30/20/30	CI
Terrace Global Inc. Appoints John Chou as Chief Financial Officer, Effective January 13, 2020	14/20/14	CI
Terrace Global Announces Appointment of Kevin Sa as Vice-President, Cultivation	30/19/30	CI
Terrace Global Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	30/19/30	CI
Terrace Global Inc. acquired Oransur, S.A. from Inception Investment Corp. for $0.005 million.	28/19/28	CI
Terrace Global Inc. Announces Plans to Open Medical Cannabis Facility in Portugal	18/19/18	CI
Apolo II Acquisition Corp. announced that it has received CAD 17 million in funding	18/19/18	CI
Terrace Global Inc. Announces Management Changes	15/19/15	CI

Chart Terrace Global Inc.

Duration

Period

More charts

Company Profile

Terrace Global Inc., formerly Apolo II Acquisition Corp., is Canada-based cannabis company. The Company is focused on the development and acquisition of cannabis assets. The Company is engaged in cultivating recreational cannabis, medical cannabis and hemp assets in Uruguay, Spain and Portugal.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+39.90%	6.01B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.06%	4.11B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.94%	3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.63%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.17%	2.31B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.13%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-5.16%	1.55B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+52.16%	1.51B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-16.04%	1.49B

Alternative Medicine